Chekhun, V., Andriiv, A., & Lukianova, N. (2017). Significance of iodine symporter for prognosis of the disease course and efficacy of neoadjuvant chemotherapy in patients with breast cancer of luminal and basal subtypes. Experimental Oncology.
Chicago-Zitierstil (17. Ausg.)Chekhun, V.F, A.V Andriiv, und N.Yu Lukianova. "Significance of Iodine Symporter for Prognosis of the Disease Course and Efficacy of Neoadjuvant Chemotherapy in Patients with Breast Cancer of Luminal and Basal Subtypes." Experimental Oncology 2017.
MLA-Zitierstil (8. Ausg.)Chekhun, V.F, et al. "Significance of Iodine Symporter for Prognosis of the Disease Course and Efficacy of Neoadjuvant Chemotherapy in Patients with Breast Cancer of Luminal and Basal Subtypes." Experimental Oncology, 2017.
Achtung: Diese Zitate sind unter Umständen nicht zu 100% korrekt.